erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment...

there was a psychological toll, too. olczyk felt he was letting down his family and friends, letting down nbc and letting down the blackhawks, for whom he regularly broadcasts games...